PMID: 6992019Feb 1, 1980Paper

Immunosuppressive therapy for external ocular inflammatory disease

Ophthalmology
C S Foster

Abstract

Fourteen patients with progressive ocular inflammation and destructive lesions, unresponsive to conventional therapy, were treated with systemic immunosuppression. Ten patients had connective tissue/vasculitis diseases; two, cicatricial pemphigoid; and two, bilateral Mooren's corneal ulcers. Control of underlying systemic disease by immunosuppression resulted invariably in concomitant control of ocular inflammation and destruction. Encouraging results were obtained in the patients with cicatricial pemphigoid and those with bilateral Mooren's ulcers.

References

Aug 1, 1978·American Journal of Ophthalmology·L M JampolM F Goldberg
Mar 1, 1976·The British Journal of Ophthalmology·P G Watson, S S Hayreh
May 1, 1968·American Journal of Ophthalmology·B Kietzman
Jun 1, 1970·The British Journal of Ophthalmology·A J Lyne
Dec 1, 1967·American Journal of Ophthalmology·D Sevel
Nov 1, 1952·American Journal of Ophthalmology·E L GOAR, L S SMITH
Oct 1, 1956·American Journal of Ophthalmology·J BOECK
Aug 1, 1965·Archives of Ophthalmology·J A REEVES
Jul 1, 1952·A.M.A. Archives of Ophthalmology·G N WISE
Oct 1, 1964·The British Journal of Ophthalmology·O Halmay, K Ludwig

❮ Previous
Next ❯

Citations

Jan 1, 1989·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·M ZierhutU Pleyer
Oct 10, 2006·Modern Rheumatology·Takeshi IdeYoshitsugu Inoue
Aug 14, 2009·American Journal of Ophthalmology·Pooja V BhatC Stephen Foster
May 1, 1990·Mayo Clinic Proceedings·D C Herman
May 26, 1999·Survey of Ophthalmology·E M Messmer, C S Foster
Nov 1, 1991·Ophthalmology·M Sainz de la Maza, C S Foster
Jan 26, 1999·Ophthalmology·S DevG J Jaffe
May 3, 2000·International Ophthalmology Clinics·C L Haupert, G J Jaffe
Jul 1, 1983·The British Journal of Ophthalmology·J S Stilma
Jan 1, 1987·The British Journal of Ophthalmology·J C Hill, P Potter
Jun 1, 1987·The British Journal of Ophthalmology·D Wakefield, L P Robinson
Jun 1, 1991·The British Journal of Ophthalmology·K N HakinS L Lightman
Jun 1, 1991·The British Journal of Ophthalmology·K N HakinS L Lightman
Sep 25, 2001·The British Journal of Ophthalmology·J R Smith, J T Rosenbaum
Jul 15, 1984·American Journal of Ophthalmology·S I Brown, B J Mondino
Jul 15, 1984·American Journal of Ophthalmology·R A ThoftC S Foster
Apr 15, 1991·American Journal of Ophthalmology·R D SacksR B O'Grady
Jan 31, 1985·Documenta Ophthalmologica. Advances in Ophthalmology·P J KruitJ S Stilma
Feb 1, 1994·Ophthalmology·M Sainz de la MazaC S Foster
Sep 1, 1993·Ophthalmology·M Sainz de la MazaC S Foster
Apr 1, 1991·Ophthalmology·L P FongC S Foster
Mar 1, 1989·Ophthalmology·M Sainz de la MazaC S Foster
Sep 1, 1992·Ophthalmology·S S ShahD M Meisler
Jul 1, 1990·Ophthalmology·T Hoang-XaunB A Rice
Aug 1, 1996·Ophthalmology·A J Flach
Feb 1, 2005·Medical Journal, Armed Forces India·K ShyamsundarK Narayanan
Aug 19, 2008·Journal of Pediatric Ophthalmology and Strabismus·William P MadiganMohamad S Jaafar
Jul 3, 2004·Survey of Ophthalmology·Victor L PerezC Stephen Foster
Jul 1, 1986·Survey of Ophthalmology·J B RobinH E Kaufman
Sep 1, 1981·Experimental Eye Research·M M RodriguesR A Eiferman
Oct 4, 2014·Saudi Journal of Ophthalmology : Official Journal of the Saudi Ophthalmological Society·Bandar Al-QahtaniImran Jalaluddin
Sep 23, 2011·Expert Opinion on Investigational Drugs·Sana S SiddiqueCharles Stephen Foster
Apr 5, 2005·Ocular Immunology and Inflammation·Sunil DeokulePhilip I Murray
May 1, 1985·Australian and New Zealand Journal of Ophthalmology·P J McCluskeyR Penny
Jan 1, 1988·Eye·C M CalthorpeA C McCartney
Dec 28, 2006·European Journal of Ophthalmology·R MalikS D Cook
Mar 4, 2021·Survey of Ophthalmology·Yogita GuptaRadhika Tandon

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.